| 1 |
27993669 | Contrasting effects of glutamine deprivation on apoptosis induced by conventionally used anticancer drugs. | 2017 Mar |
1 |
| 2 |
28702823 | Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis. | 2017 Oct |
4 |
| 3 |
24732433 | Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer. | 2014 May 1 |
1 |
| 4 |
23124518 | Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL. | 2012 Jun 21 |
5 |
| 5 |
21751122 | Combination of IFNγ and chemotherapeutic agents increase TRAIL sensitivity of neuroblastoma cell lines. | 2011 Oct |
1 |
| 6 |
16923369 | [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells]. | 2006 Aug |
2 |
| 7 |
15964798 | Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. | 2005 Jul |
2 |
| 8 |
16123594 | The two faces of NFkappaB in cell survival responses. | 2005 Oct |
2 |
| 9 |
12838325 | Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. | 2003 Jul 7 |
1 |
| 10 |
14500373 | Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. | 2003 Sep 1 |
1 |
| 11 |
11803469 | TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. | 2002 Jan 10 |
1 |
| 12 |
11916527 | Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines. | 2002 May |
1 |
| 13 |
10594023 | Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. | 2000 Jan |
2 |
| 14 |
10706092 | Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. | 2000 Feb 15 |
2 |
| 15 |
11090076 | Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. | 2000 Dec 1 |
2 |